What's Happening?
On November 21, 2026, 89 open market insider transactions were reported. Among the notable purchases, Dave Girouard bought 60,000 shares of UPSTART HOLDINGS, INC. ($UPST) on November 20 for an estimated $950,988. In the past six months, UPST insiders
have conducted 26 open market trades, with 5 purchases and 21 sales. Key insider activities for UPST include Sanjay Datta selling 312,533 shares for approximately $7,379,009, Paul Gu buying 200,000 shares for about $4,115,965, and Andrea Blankmeyer selling 22,674 shares for an estimated $536,969. Additionally, Kevin Tang purchased 41,461 shares of BOUNDLESS BIO, INC. ($BOLD) on November 19 for an estimated $98,262. Over the last six months, BOLD insiders have made 43 open market trades, comprising 40 purchases and 3 sales. Kevin Tang's activity for BOLD includes 40 purchases totaling 923,779 shares for approximately $2,250,849 and one sale of 18,300 shares for about $54,351.
Why It's Important?
Insider trading activity, particularly open market purchases, can signal confidence in a company's future prospects from those with the most intimate knowledge of its operations. When executives and directors invest their own capital into company stock, it often suggests they believe the stock is undervalued or that significant positive developments are on the horizon. Conversely, a high volume of insider sales might indicate concerns about future performance or simply be for personal financial planning. For UPSTART HOLDINGS, INC., the recent purchase by Dave Girouard, alongside other insider buying, could be interpreted by investors as a positive indicator, despite a higher number of sales over the past six months. For BOUNDLESS BIO, INC., the substantial number of insider purchases, particularly by Kevin Tang, suggests strong internal belief in the company's trajectory, which could influence broader market sentiment and investor decisions. These transactions provide valuable data points for investors analyzing the health and potential of these companies.
What's Next?
Investors will likely monitor subsequent insider trading reports for both UPSTART HOLDINGS, INC. and BOUNDLESS BIO, INC. to discern any emerging trends or shifts in insider sentiment. Continued insider buying could reinforce positive market perceptions, potentially leading to increased investor interest and stock price appreciation. Conversely, a sudden increase in insider selling could trigger caution among investors. Analysts will also be looking for corporate announcements, earnings reports, or other material news from these companies that might correlate with or explain the recent insider activity. The market's reaction to these insider transactions will depend on various factors, including the overall economic climate, sector-specific news, and the companies' individual performance metrics. Future regulatory filings will provide ongoing transparency into these insider movements, allowing the public to track these developments.
Beyond the Headlines
The practice of tracking insider trading extends beyond simple stock market analysis; it touches upon corporate governance and transparency. While legal, insider trading is heavily regulated to prevent unfair advantages based on non-public information. The public disclosure of these transactions, as facilitated by platforms like Quiver Quantitative, aims to level the playing field by making this information accessible to all investors. The patterns of insider buying and selling can also reflect broader industry trends or shifts in investor confidence within specific sectors, such as technology for Upstart Holdings or biotechnology for Boundless Bio. Understanding these dynamics can offer insights into the health of these sectors and the broader economy. The ongoing scrutiny of insider trades underscores the importance of ethical conduct in financial markets and the continuous effort to ensure fair and equitable access to information for all participants.













